Medicare Enrolled

Dr. Aaron Farberg, M.D.

MOHS-Micrographic Surgery Physician · Rockwall, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Speaking/Promotional
1005 W RALPH HALL PKWY STE 207, Rockwall, TX 75032
9724303888
In practice since 2012 (13 years)
NPI: 1134480239 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Farberg from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Farberg? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Farberg

Dr. Aaron Farberg is a mohs-micrographic surgery physician in Rockwall, TX, with 13 years in practice. Based on federal Medicare data, Dr. Farberg performed 4,164 Medicare services across 1,488 unique beneficiaries.

Between the years covered by Open Payments, Dr. Farberg received a total of $1,070,795 from 47 pharmaceutical and/or device companies across 1401 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in mohs-micrographic surgery physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Farberg is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice▲ Top 24% volume in TX$ $1,070,795 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,164
Medicare services
Top 24% in TX for mohs-micrographic surgery physician
1,488
Unique beneficiaries
$130
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~320 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Destruction of precancerous skin growths, 2-14645$5$11
Obtaining data needed to develop the optimal radiation treatment, 1 treatment area552$209$479
Superficial and/or low voltage radiation treatment delivery533$32$73
Ultrasonic guidance for placement of radiation therapy fields486$140$319
Relese, per square centimeter238$565$1,442
New patient office visit (30-44 min)193$77$168
Skin biopsy, tangential163$65$163
Destruction of precancerous skin growth, 1154$34$104
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks125$473$1,186
Pathology examination of specimen during surgery, first tissue block118$80$179
Biopsy of related skin growth, each additional growth104$39$79
Office visit, established patient (20-29 min)94$70$154
Destruction of skin growths (warts/lesions), 1-1488$80$176
Radiation treatment management, 5 treatment sessions82$150$340
Continuing radiation therapy consultation per week81$66$154
Office visit, established patient (30-39 min)53$97$233
Calculation of radiation therapy dose52$51$117
Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm51$189$831
Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks46$321$729
New patient office or other outpatient visit, 15-29 minutes31$48$105
Destruction of precancer skin growth, 15 or more growths29$129$266
New patient office visit (45-59 min)29$110$268
Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm26$237$728
Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks25$430$1,143
Office visit, established patient (10-19 min)23$44$97
Simple radiation therapy planning22$55$123
Drug injection, under skin or into muscle22$11$23
Application of skin substitute graft to wound of face, scalp, eyelids, mouth, neck, ears, around eyes, genitals, hands, feet, fingers, or toes, 25.0 sq cm or less of wound 100.0 sq cm or less21$94$287
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm20$101$443
Complicated repair of wound of trunk, 2.6-7.5 cm19$247$710
Pathology examination of specimen during surgery, each additional tissue block16$43$95
Punch biopsy, first skin growth12$94$189
Tissue pathology examination, moderate complexity11$26$54
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
3.2% high complexity
50.6% medium
46.1% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,070,795
Total received (2018-2024)
Avg $152,971/year across 7 years
Top 0% in TX for mohs-micrographic surgery physician
47
Companies
1,401
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$879,918 (82.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$155,843 (14.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$35,034 (3.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$444,054
2023
$395,723
2022
$131,623
2021
$53,842
2020
$18,487
2019
$22,973
2018
$4,094

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$136,189
PFIZER INC.
$130,668
Boehringer Ingelheim Pharmaceuticals, Inc.
$121,034
Janssen Biotech, Inc.
$116,013
Galderma Laboratories, L.P.
$92,491
E.R. Squibb & Sons, L.L.C.
$86,112
Sun Pharmaceutical Industries Inc.
$83,213
Incyte Corporation
$49,839
SUN PHARMACEUTICAL INDUSTRIES INC.
$46,383
Ortho Dermatologics, a division of Bausch Health US, LLC
$33,613
Novartis Pharmaceuticals Corporation
$32,340
Boehringer Ingelheim International GmbH
$30,013
ABBVIE INC.
$21,922
GENZYME CORPORATION
$15,130
Janssen Scientific Affairs, LLC
$14,251
Almirall LLC
$11,020
NOVARTIS PHARMACEUTICALS CORPORATION
$10,883
Dermavant Sciences, Inc.
$9,119
Amgen Inc.
$8,625
Pfizer Inc.
$5,365
Celgene Corporation
$2,749
DERMIRA, INC.
$2,666
Sensus Healthcare, Inc.
$2,517
UCB, Inc.
$2,163
EPI Health, LLC
$1,500
Biofrontera Inc.
$885
Lilly USA, LLC
$844
Verrica Pharmaceuticals Inc.
$648
AbbVie Inc.
$614
LEO Pharma Inc.
$398
AbbVie, Inc.
$377
Arcutis Biotherapeutics, Inc.
$215
Genentech USA, Inc.
$193
MAYNE PHARMA COMMERCIAL LLC
$135
Kerecis Limited
$122
Allergan Inc.
$121
Regeneron Pharmaceuticals, Inc.
$89
Misonix Inc
$67
SANOFI-AVENTIS U.S. LLC
$66
Mayne Pharma Inc.
$50
Journey Medical Corporation
$40
DUSA Pharmaceuticals, Inc.
$25
MAYNE PHARMA INC.
$22
Midsouth Orthopedics
$21
Kyowa Kirin, Inc.
$19
MIMEDX Group, Inc.
$14
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 36.2% of total payments
Associated products mentioned in payments ›
20% · ABSORICA · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · ARAZLO · ATRALIN · Ameluz · BLU-U · Bimzelx · CIBINQO · COSENTYX · Cabtreo · Cimzia · DERMATITIS - DISEASE · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · DYSPORT · EBGLYSS · ENSTILAR · EPIDUO FORTE · EPSOLAY · EUCRISA · Enbrel · Erivedge · FINACEA · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · INFLECTRA · Ilumya · JUBLIA · Kerecis Omega3 SurgiClose · Klisyri · LEVULAN KERASTICK · LIBTAYO · LITFULO · Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution · ODOMZO · OLUMIANT · ONEXTON · OPZELURA · ORACEA · Odomzo · Otezla · Poteligeo · QBREXZA · REMICADE · RENFLEXIS · RETIN-A-MICRO · RINVOQ · SILIQ · SKYRIZI · SOOLANTRA · SPEVIGO · Seysara · Skyrizi · Sotyktu · TALTZ · TREMFYA · TWYNEO · Tremfya · VTAMA · WYNZORA · Winlevi · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (82%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in mohs-micrographic surgery physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for mohs-micrographic surgery physician in TX.

Equivalent to $25,716 per 100 Medicare services performed
Looking for a mohs-micrographic surgery physician in Rockwall?
Compare mohs-micrographic surgery physicians in the Rockwall area by procedure volume, costs, and industry payment transparency.
Browse mohs-micrographic surgery physicians nearby

Geographic Context

MOHS-Micrographic Surgery Physicians within 10 mi
10
Per 100K population
8.6
County median income
$124,917
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL ROCKWALL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Farberg is a mixed practice specialist, with above-average Medicare volume (top 24% in TX), and high industry engagement (speaking/promotional, top 0%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Farberg experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Farberg performed 645 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Farberg receive payments from pharmaceutical companies?
Yes. Dr. Farberg received a total of $1,070,795 from 47 companies across 1,401 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Farberg's costs compare to other mohs-micrographic surgery physicians in Rockwall?
Dr. Farberg's average Medicare payment per service is $130. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Farberg) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →